Carerx Corporation · TSX:CRRX

Carerx — Q3 2025 Earnings Presentation

11 slides from Carerx's earnings presentation, Nov 4, 2025

  1. Slide 1: Q3 2025 Earnings Call

    Q3 2025 Earnings Call November 4, 2025

  2. Slide 2: Cautionary Statements

    Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past pe

  3. Slide 3: Highlights and Growth Momentum

    Highlights and Growth Momentum Puneet Khanna President & Chief Executive Officer

  4. Slide 4: Q3 2025 Summary

    Q3 2025 Summary $93.2 Million $1.6 Million Revenue Net Income $8.3 Million 9.0% Adjusted EBITDA1 Adjusted EBITDA Margin1 91,298 Average Beds Serviced1 1. Adjusted EBITDA is a non-IFRS financial measure and Adjusted EBITDA Margin is a non-IFRS ratio. Average Beds Serviced is a is a supplementary fina

  5. Slide 5: Business Highlights

    Business Highlights • Hosted Ontario Minister of LTC at CareRx Oakville Pharmacy location • October 15, 2025, paid dividend of $0.02 per share • Renewed Normal Course Issuer Bid 5

  6. Slide 6: Operating and Financial Results

    Operating and Financial Results Suzanne Brand Chief Financial Officer

  7. Slide 7: Q3 2025 Financial Results

    Q3 2025 Financial Results As at September 30, 2025 Year-over-year: Average Beds Serviced1 • Revenue remained stable, reflecting a change 91,298 vs 89,099 in Q3 2024 in the mix of branded and generic Revenue pharmaceuticals dispensed, even as the number of Average Beds Serviced¹ increased $93.2 milli

  8. Slide 8: Q3 2025 Balance Sheet

    Q3 2025 Balance Sheet As at September 30, 2025 Quarter-over-quarter: • Net Debt improved due to increase in Cash cash balance $15.5 million vs $8.7 million at Q2 2025 • Net Debt to Adjusted EBITDA improvement due to a decrease in Net Debt and Net Debt1 increase in run-rate Adjusted EBITDA $28.8 mill

  9. Slide 9: Final Perspectives

    Final Perspectives Puneet Khanna President & Chief Executive Officer

  10. Slide 10: Final Perspectives

    Final Perspectives • Voices of CareRx video series • Medication Safety in LTC presentation for ISMP Canada • Community support LTC Engagement Day, Strides for Seniors Walk/Run 10

  11. Slide 11: Slide 11

CareRx — Q3 2025 Earnings Presentation on 6ix